Both in Pharmaceuticals
Korsana Biosciences vs Rapport Therapeutics
Over the past year KRSA returned −0.8% and RAPP returned −42.4%; their daily moves had a correlation of 0.03.
KRSA −0.8% RAPP −42.4%Growth of $1, one year, split-adjusted
| Metric | KRSA | RAPP |
|---|---|---|
| Price | $31.66 | $25.13 |
| Market cap | $1.44B | $1.42B |
| Today | +5.04% | +0.32% |
| 1 month | +3.8% | −21.9% |
| 6 months | — | −29.3% |
| Year to date | — | −17.2% |
| 1 year | — | −6.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 70.8× |
| Net cash | — | $436.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 79.9% |
| Short % of float | 1.0% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).